Pharmacogenetic aspects of substance use disorders

QR Code

Pharmacogenetic aspects of substance use disorders

The substance use disorders Diseases of substance dependence (SAW) represent the «pharmacogenetic» diseases caused by abnormal and genetically determined response of the CNS to use of the substance of abuse (SA), conscious and regulated by person itself. Genetic differences in the pharmacodynamics o...

Full description

Saved in:

Bibliographic Details
Main Author:	A. O. Kibitov
Format:	Article
Language:	Russian
Published:	Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2018-07-01
Series:	Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:	наркология генетика наследственность фармакогенетика генетический риск полиморфизм генов опиоидные рецепторы дофамин drug and alcohol abuse genetics heredity pharmacogenetics genetic risk gene polymorphism opioid receptors dopamine
Online Access:	https://www.bekhterevreview.com/jour/article/view/160
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MONOCYTES AND GRANULOCYTES LIPOPOLYSACCHARIDE-CONNECTING POTENTIAL AT GRAVE'S DISEASE PATIENTS IN INTERRELATION WITH C(-159)T POLYMORPHISM OF CD14 MONOCYTES RECEPTORS
by: V. A. Beloglazov, et al.
Published: (2014-08-01)

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
by: T. P. Rozina, et al.
Published: (2018-08-01)

Comparative pharmacogenetic study of disulfiram or cyanamide efficacy for alcohol dependence: the key role of dopamine neurotransmission gene polymorphisms
by: A. O. Kibitov, et al.
Published: (2023-07-01)

THE PROGNOSTIC VALUE OF PHARMACOLOGICAL AND GENETIC TESTING IN MEDICAL THERAPY OF AGE-RELATED MACULAR DEGENERATION
by: N. A. Bakunina, et al.
Published: (2018-10-01)

Генетический полиморфизм и фармакокинетика лекарственных средств
Published: (2005-03-01)

Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia
by: M. V. Sokolova, et al.
Published: (2018-08-01)

Unfavourable factors promoting development of myopia among the students of medical colleges
by: I. M. Valiakhmetova, et al.
Published: (2014-03-01)

Genetic features of the dopaminergic neurotransmitter system in patients with alcohol dependence and depression comorbidity
by: A. E. Nikolishin, et al.
Published: (2019-12-01)

Monitoring post-approval drug safety in pregnancy: pharmacogenetic aspects
Published: (2018-02-01)

The effectiveness of the preventive program aimed at the formation of sobriety in alcohol abusers does not depend on the level of genetic risk of substance abuse
by: V. B. Vantej, et al.
Published: (2019-12-01)

Modification of immune response genes in various types of chronic lymphocytic leukemia
by: E. L. Nazarova, et al.
Published: (2015-03-01)

Exploring genetic predictors of naltrexone treatment response in opioid use disorder
by: Е. A. Blokhina ., et al.
Published: (2019-12-01)

Heredity /
by: Fradin, Dennis B.
Published: (1987)

General genetics /
by: Srb, Adrian M.
Published: (1965)

GRIGORY ANDREEVICH LEVITSKY
by: L. I. Orel, et al.
Published: (2018-06-01)

Genetic testing for forecasting and course of the chronic heart failure against the background arterial hypertension
by: A. L. Khokhlov, et al.
Published: (2018-02-01)

Markers of endothelial dysfunction in pregnant women with the A2 gene polymorphism of platelet glycoprotein receptors IIb/IIIa
by: A. Y. Muratova, et al.
Published: (2016-02-01)

Stabilization of remission in patients with opioid depen dence: pharmacological and pharmacogenetic aspects
by: V. Ya. Palatkin, et al.
Published: (2016-12-01)

Pharmacogenetics of antipsychotic-induced metabolic disturbances: state-of-the-art
by: R. F. Nasyrova, et al.
Published: (2018-07-01)

Genetic risks of addictive disorders in adolescents: phenotypic effects
by: A. N. Yakovlev, et al.
Published: (2019-12-01)

Variability of response to pharmacotherapy of naltrexone and guanfacin in patients with opioid dependence syndrome: pharmacogenetic aspect
by: V. Ya Palatkin, et al.
Published: (2019-12-01)

Pharmacogenetic testing: current state of the issue
by: O. V. Kraidashenko, et al.
Published: (2024-11-01)

The role of opioid peptides in the regulation of secretin-stimulated bile secretion
by: M. A. Medvedev, et al.
Published: (2006-09-01)

APOPTOTIC ACTIVITY AS A TRIGGER MECHANISM OF SYSTEMIC FIBROSIS OF INTERNAL ORGANS IN MINERS
by: Олег Иванович Бондарев, et al.
Published: (2022-09-01)

CLINICAL AND EXPERIMENTAL STUDY OF THE EFFECTS OF THE LONG-TERM ACTION OF SODIUM FLUORIDE ON THE MOLECULAR-GENETIC MECHANISMS OF BONE TISSUE REMODELING
by: Анна Геннадьевна Жукова, et al.
Published: (2017-09-01)

ANALYSIS OF POLYMORPHISM OF THE GENES OF THE PHASE II OF XENOBIOTICS BIOTRANSFORMATION (GSTM1, GSTT1) IN THE SHORIANS AND ALIEN POPULATION OF THE KEMEROVO REGION: THE PROBLEM OF THE DIFFERENCES IN MORTALITY RATE FROM MALIGNANT NEOPLASMS
by: Фаина Анисимовна Лузина, et al.
Published: (2017-10-01)

The role of polymorphism (rs1800566) of NAD(F)H quinone oxidoreductase-1 in development of acute pancreatitis
by: T. A. Samgina, et al.
Published: (2018-08-01)

Pharmacogenetics of anti-seizure medications in Arab countries: a comprehensive review
by: Rania Magadmi
Published: (2025-12-01)

POLYMORPHISM C634G OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR A GENE IN PATIENTS WITH DIABETIC FOOT IN THE TRANS-BAIKAL TERRITORY
by: Наталья Игоревна Троицкая, et al.
Published: (2023-08-01)

THE STATE OF THE MICROCIRCULATORY BED IN DIABETIC FOOT SYNDROME WITH THE CARRIAGE OF VARIOUS VARIANTS OF THE T1565C POLYMORPHISM GENOTYPES OF THE ITGB3 GENE
by: Наталья Игоревна Троицкая, et al.
Published: (2022-11-01)

ROLE OF CYP1B1 GENE POLYMORPHISM IN THE DEVELOPMENT OF POSTMENOPAUSAL OSTEOPOROSI
by: Игорь Сергеевич Захаров, et al.
Published: (2017-03-01)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01)

The role of genetic research with family design in the study of affective disorders
by: E. D. Kasyanov, et al.
Published: (2019-12-01)

Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
by: N. A. Shnayder, et al.
Published: (2024-07-01)

Prospects of using C3435T polymorphism in the <i>ABCB1</i> gene encoding P-glycoprotein in personalised medicine
by: R. E. Kazakov, et al.
Published: (2018-02-01)

The role of μ-opioid receptors in the regulation of hepatic secretory function
by: M. A. Medvedev, et al.
Published: (2006-06-01)

Mechanisms of formation comorbidity depression and obesity
by: G. E. Mazo, et al.
Published: (2018-07-01)

Substance abuse : pharmacologic, developmental, and clinical perspectives /
Published: (1983)

Population biobank as a basis for determining spatial variation of clinically relevant pharmacogenetic biomarkers of cardiovascular diseases
by: V. Yu. Pylev, et al.
Published: (2022-12-01)

Gregor Mendel: my time will come
by: Yu. M. Novikov
Published: (2015-07-01)